Raymond James Financial’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.64M	Buy	332,089 +13,849	+4%	+$194K	﹤0.01%	2429
2025 Q1	$4.29M	Buy	318,240 +4,453	+1%	+$60K	﹤0.01%	2440
2024 Q4	$6.02M	Buy	+313,787	New	+$6.02M	﹤0.01%	2200